BMAL1 and pneumococcal infection: Both mouse lines showed striking protection from bacteraemia (blood culture positive), 48 h after pneumococcal infection, but the LysM-Bmal1−/− mice also showed reduced lung bacterial burden, and a trend toward reduced bacteraemia was seen at 24 h following inoculation (SI Appendix, Fig. S1B).